Filana Therapeutics
FLNA
49 hedge funds and large institutions have $37.2M invested in Filana Therapeutics in 2015 Q3 according to their latest regulatory filings, with 3 funds opening new positions, 11 increasing their positions, 19 reducing their positions, and 20 closing their positions.
200% more call options, than puts
Call options by funds: $15K | Put options by funds: $5K
5% more capital invested
Capital invested by funds: $35.6M → $37.2M (+$1.61M)
26% less funds holding
Funds holding: 66 → 49 (-17)
42% less repeat investments, than reductions
Existing positions increased: 11 | Existing positions reduced: 19
85% less first-time investments, than exits
New positions opened: 3 | Existing positions closed: 20
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
BI
BVF Inc
San Francisco,
California
|
+$1.67M |
| 2 |
Renaissance Technologies
New York
|
+$138K |
| 3 |
BCM
Bridgeway Capital Management
Houston,
Texas
|
+$129K |
| 4 |
Connor, Clark & Lunn Investment Management (CC&L)
Vancouver,
British Columbia, Canada
|
+$66.5K |
| 5 |
Vanguard Group
Malvern,
Pennsylvania
|
+$64.2K |
Top Sellers
FLNA Hedge Fund Activity: Q3 2015 in Review
49 of the 3,582 institutional investors tracked by Wall St. Rank reported a position in Filana Therapeutics (FLNA) for Q3 2015, worth a combined $37.2M — up 4.5% from $35.6M a quarter earlier.
Sellers outnumbered buyers: 20 funds closed out of FLNA and 3 opened new positions — a net loss of 17 holders — while 19 trimmed existing stakes and 11 added.
The largest buyer was BVF Inc, opening a new position worth an estimated $1.67M. The largest seller was Northern Trust, cutting an estimated $546K.
- 49 institutional investors held Filana Therapeutics (FLNA) as of Q3 2015, down from 66 in Q2 2015.
- Funds reported $37.2M of Filana Therapeutics stock for Q3 2015, up 4.5% quarter-over-quarter.
- 3 funds opened new Filana Therapeutics positions in Q3 2015 and 20 closed out, a net change of -17 holders.
- The largest Filana Therapeutics buyer in Q3 2015 was BVF Inc, an estimated $1.67M added.
- The largest Filana Therapeutics seller in Q3 2015 was Northern Trust, an estimated $546K sold.
Based on aggregated 13F filings for Q3 2015.